Rescue of disabled infectious single-cycle (DISC) Equine arteritis virus by using complementing cell lines that express minor structural glycoproteins

References

1. Agapov E. V., Frolov I., Lindenbach B. D., Prágai B. M., Schlesinger S., Rice C. M. 1998; Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc Natl Acad Sci U S A 95:12989–12994 [CrossRef]
   [Google Scholar]
2. Boursnell M. E. G., Entwisle C., Blakeley D. 9 other authors 1997; A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J Infect Dis 175:16–25 [CrossRef]
   [Google Scholar]
3. den Boon J. A., Snijder E. J., Chirnside E. D., de Vries A. A. F., Horzinek M. C., Spaan W. J. M. 1991; Equine arteritis virus is not a togavirus but belongs to the coronaviruslike superfamily. J Virol 65:2910–2920
   [Google Scholar]
4. de Vries A. A. F., Chirnside E. D., Horzinek M. C., Rottier P. J. M. 1992; Structural proteins of equine arteritis virus. J Virol 66:6294–6303
   [Google Scholar]
5. de Vries A. A. F., Post S. M., Raamsman M. J. B., Horzinek M. C., Rottier P. J. M. 1995; The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers. J Virol 69:4668–4674
   [Google Scholar]
6. de Vries A. A. F., Glaser A. L., Raamsman M. J. B., de Haan C. A. M., Sarnataro S., Godeke G.-J., Rottier P. J. M. 2000; Genetic manipulation of equine arteritis virus using full-length cDNA clones: separation of overlapping genes and expression of a foreign epitope. Virology 270:84–97 [CrossRef]
   [Google Scholar]
7. McLean C. S., Erturk M., Jennings R., Ní Challanáin D., Minson A. C., Duncan I., Boursnell M. E. G., Inglis S. C. 1994; Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J Infect Dis 170:1100–1109 [CrossRef]
   [Google Scholar]
8. McLean C. S., Ní Challanáin D., Duncan I., Boursnell M. E. G., Jennings R., Inglis S. C. 1996; Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine. Vaccine 14:987–992 [CrossRef]
   [Google Scholar]
9. Meulenberg J. J. M., Bos-de Ruijter J. N. A., van de Graaf R., Wensvoort G., Moormann R. J. M. 1998; Infectious transcripts from cloned genome-length cDNA of porcine reproductive and respiratory syndrome virus. J Virol 72:380–387
   [Google Scholar]
10. Molenkamp R., van Tol H., Rozier B. C. D., van der Meer Y., Spaan W. J. M., Snijder E. J. 2000; The arterivirus replicase is the only viral protein required for genome replication and subgenomic mRNA transcription. J Gen Virol 81:2491–2496
    [Google Scholar]
11. Nielsen H. S., Oleksiewicz M. B., Forsberg R., Stadejek T., Bøtner A., Storgaard T. 2001; Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J Gen Virol 82:1263–1272
    [Google Scholar]
12. Nielsen H. S., Liu G., Nielsen J., Oleksiewicz M. B., Bøtner A., Storgaard T., Faaberg K. S. 2003; Generation of an infectious clone of VR-2332, a highly virulent North American-type isolate of porcine reproductive and respiratory syndrome virus. J Virol 77:3702–3711 [CrossRef]
    [Google Scholar]
13. Pasternak A. O., van den Born E., Spaan W. J. M., Snijder E. J. 2001; Sequence requirements for RNA strand transfer during nidovirus discontinuous subgenomic RNA synthesis. EMBO J 20:7220–7228 [CrossRef]
    [Google Scholar]
14. Rees R. C., McArdle S., Mian S., Li G., Ahmad M., Parkinson R., Ali S. A. 2002; Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer. Curr Opin Mol Ther 4:49–53
    [Google Scholar]
15. Snijder E. J., Meulenberg J. J. M. 2001; Arteriviruses. In Fields Virology , 4th edn. pp  1205–1220 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott, Williams & Wilkins;
    [Google Scholar]
16. Snijder E. J., van Tol H., Pedersen K. W., Raamsman M. J. B., de Vries A. A. F. 1999; Identification of a novel structural protein of arteriviruses. J Virol 73:6335–6345
    [Google Scholar]
17. Todryk S., McLean C., Ali S., Entwistle C., Boursnell M., Rees R., Vile R. 1999; Disabled infectious single-cycle herpes simplex virus as an oncolytic vector for immunotherapy of colorectal cancer. Hum Gene Ther 10:2757–2768 [CrossRef]
    [Google Scholar]
18. van der Meer Y., van Tol H., Krijnse Locker J., Snijder E. J. 1998; ORF1a-encoded replicase subunits are involved in the membrane association of the arterivirus replication complex. J Virol 72:6689–6698
    [Google Scholar]
19. van Dinten L. C., den Boon J. A., Wassenaar A. L. M., Spaan W. J. M., Snijder E. J. 1997; An infectious arterivirus cDNA clone: identification of a replicase point mutation that abolishes discontinuous mRNA transcription. Proc Natl Acad Sci U S A 94:991–996 [CrossRef]
    [Google Scholar]
20. Wieringa R., de Vries A. A. F., Post S. M., Rottier P. J. M. 2003; Intra- and intermolecular disulfide bonds of the GP_2b glycoprotein of equine arteritis virus: relevance for virus assembly and infectivity. J Virol 77:12996–13004 [CrossRef]
    [Google Scholar]
21. Wieringa R., de Vries A. A. F., van der Meulen J. 7 other authors 2004; Structural protein requirements in equine arteritis virus assembly. J Virol (in press
    [Google Scholar]